Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

The document concludes that hair restoration has advanced significantly, with FUE becoming more popular, and stresses the importance of physician training and ethical practices in the field.

The convention highlighted knowledge sharing, networking, and the importance of active participation in dermatology.

Glycated hemoglobin is not as effective as the oral glucose tolerance test for diagnosing blood sugar problems in women with PCOS in Southern Iraq.

Hair testing is a reliable method for detecting workplace drug use when done with proper sample preparation and confirmation.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

Researchers identified new compounds in Platycladi Cacumen and found variations in its flavonoid content, which could aid in its quality control.

PRGF treatment is safer and more effective for hair loss than topical minoxidil.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Unusual fungal structures were found in a boy's scalp infection, successfully treated with medication.

Some off-label treatments increase hair density, but long-term safety unknown.

Higher substance P levels may cause discomfort in hair loss patients.

The conclusion is that normal trace element levels in newborn calves' hair are between the 25th and 75th percentiles, and levels outside this may indicate diselementosis.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Trichoscopy is essential for early detection and monitoring of female-pattern hair loss.

The first in-prison dermatology clinic in the U.S. faced challenges and found certain skin conditions common among inmates, with rare cases of serious skin cancer.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

Two new reliable Arabic questionnaires for measuring quality of life in women with PCOS were created, one for married and one for unmarried women.

The treatment improved hair thickness, shine, and reduced hair loss effectively.